Nestlé acquired Atrium Innovations, bringing the Pure Encapsulations brand into a much larger company, according to a LinkedIn post recounting the deal. The transaction is described as completed. No purchase price was disclosed in the source.
The same post notes that Thorne merged with Diversified Natural Products and that Al Czap stepped back from leadership at that time. It also states that P&G has agreed to acquire Thorne, and that Nestlé is keeping Pure while selling several of its mainstream supplement brands.
According to the post, the earlier ownership changes did not disrupt practitioner recommendations. Providers kept recommending both brands, which continued to grow in the practitioner channel while becoming more visible to consumers. The author, who writes that they worked at Natural Partners and Fullscript, describes seeing Thorne branding inside the UFC Octagon and a Pure Encapsulations ad while streaming television.
The post raises questions about what happens when patients already know a supplement brand and can buy it directly. It argues clinical judgment matters, since a provider can assess whether a supplement makes sense, interpret labs when appropriate, consider the rest of a patient's care, and follow up on results. It also frames a business question: a patient may value that guidance but purchase the product elsewhere, and if that becomes routine, what happens to product sales and the ongoing relationship between patient, provider, and brand. The author asks practitioners whether these brands are bringing more informed patients into their practices, whether purchases are moving outside it, and whether any of this has changed what they recommend.